Relief Therapeutics Holding AG
WHO'M
ai
Digital Profiler. Simply click the AI button
FIGI: -
RLF
Relief Therapeutics Holding AG
GICS: -
·
Sector: -
·
Sub-Sector: -
NAME
Relief Therapeutics Holding AG
ISIN
CH0100191136
TICKER
RLF
MIC
XSWX
REUTERS
RLF.S
BLOOMBERG
RLF SW
Financial Intelligence
FOR INVESTORS
FOR TRADERS
Securities Trading
Warrants
EQS Newswire is a major provider of regulatory and corporate news. It mainly serves companies, investors and media worldwide. Through its services, EQS Newswire enables efficient and secure communication between companies and their stakeholders. Its main services include the distribution of ad hoc announcements, corporate news and the publication of financial reports that meet strict international standards.
Wed, 18.09.2024
Relief Therapeutics Holding SA
/ Key word(s): Study
Relief Therapeutics Completes Clinical Phase in RLF-OD032 Proof-of-Concept Study; Topline Results Expected in October 2024
18.09.2024 / 07:00 CET/CEST
Relief Therapeutics Completes Clinical Phase in RLF-OD032 Proof-of-Concept Study; Topline Results Expected in October ...
Mon, 02.09.2024
Relief Therapeutics Holding SA
/ Key word(s): Study
Relief Therapeutics Announces PKU GOLIKE Study Results Presentation at SSIEM 2024
02.09.2024 / 07:00 CET/CEST
Relief Therapeutics Announces PKU GOLIKE Study Results Presentation at SSIEM 2024
GENEVA (SEPT. 2, 2024) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RL...
Fri, 30.08.2024
Relief Therapeutics Reports Half-Year 2024 Financial Results and Provides Corporate Update
RLF-TD011 investigator-initiated trial results for EB wound treatment anticipated in the coming weeks
RLF-OD032 pilot PK study progresses with potential NDA filing by mid- to late 2025
Streamlined operations and CHF 15.1 million cash reserves expected to p...
Thu, 30.05.2024
Relief Therapeutics Announces Notice of Annual General Meeting of Shareholders
GENEVA (MAY 30, 2024) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select rare diseases, today announced the Annual General Meeting (AGM) o...
Tue, 30.04.2024
Relief Therapeutics has published its Annual Report
GENEVA (APR. 30, 2024) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today published its Annual Report 2023 and provided a corporate update....
Wed, 27.03.2024
RELIEF THERAPEUTICS Holding SA to Hold Extraordinary General MeetingRelief Therapeutics Calls Extraordinary General Meeting
Anticipated Board of Directors Overhaul
GENEVA (MAR. 27, 2024) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief Therapeutics, or the Company), a biopharmaceutical company committed to delivering innova...
Fri, 22.03.2024
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE®
GENEVA (MAR. 22, 2024) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare...
Wed, 28.02.2024
Relief Therapeutics Renews CHF 50 million Share Subscription Facility
3-year CHF 50 million capital commitment from GEM
Relief advances strategic transformation
GENEVA (FEB. 28, 2024) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment ...
Tue, 05.12.2023
Relief Therapeutics Shifts Commercial Operations to Partnership Model, Focusing on Efficient Patient Access and R&D Growth
GENEVA (DEC. 5, 2023) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet ...
Wed, 22.11.2023
Relief Therapeutics Announces CEO Transition
GENEVA (NOV. 22, 2023) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today announced that its current chief executive officer (CEO)...
Information on product placements
